Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
05/22/201910:25AMInvestorsHub NewsWireCBD Medical Plays to WatchNASDAQ:IMGNImmunoGen Inc
05/17/20197:00AMInvestorsHub NewsWireBiotech Stock Closing in on Human TrialsNASDAQ:IMGNImmunoGen Inc
05/15/20194:01PMBusiness WireImmunoGen Announces Mature Data from FORWARD II Expansion Cohort Evaluating Mirvetuximab Soravtansine in Combination with Ava...NASDAQ:IMGNImmunoGen Inc
05/15/20195:45AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
05/15/20195:30AMBusiness WireImmunoGen Provides Regulatory Update on Mirvetuximab Soravtansine Monotherapy in Ovarian CancerNASDAQ:IMGNImmunoGen Inc
05/09/20193:58PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
05/07/20192:57PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
05/03/20195:37AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
05/03/20195:30AMBusiness WireImmunoGen Reports Recent Progress and First Quarter 2019 Financial ResultsNASDAQ:IMGNImmunoGen Inc
04/30/201911:24AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IMGNImmunoGen Inc
04/30/201911:20AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IMGNImmunoGen Inc
04/18/20193:30PMBusiness WireImmunoGen Announces Conference Call to Discuss Its First Quarter 2019 Operating ResultsNASDAQ:IMGNImmunoGen Inc
04/08/201912:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
04/01/201910:33AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
04/01/201910:33AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
03/19/20194:17PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:IMGNImmunoGen Inc
03/19/20199:20AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:IMGNImmunoGen Inc
03/01/20193:55PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:IMGNImmunoGen Inc
03/01/20196:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
03/01/20195:30AMBusiness WireImmunoGen Announces Top-Line Results from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine in Ovarian CancerNASDAQ:IMGNImmunoGen Inc
02/27/20193:31PMBusiness WireImmunoGen Announces Multiple Presentations at AACR Annual MeetingNASDAQ:IMGNImmunoGen Inc
02/25/20199:13AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/25/20199:12AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/25/20199:12AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/25/20199:12AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/25/20199:11AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/25/20199:11AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/14/20193:25PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/14/20191:28PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/14/20196:50AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN

Your Recent History

Delayed Upgrade Clock